Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?

Kidney transplantation is a well-established therapy for patients with end-stage renal disease. While a significant improvement of short-term results has been achieved in the short-term, similar results were not reported in the long-term. Heme-oxygenase (HO) is the rate-limiting enzyme in heme catab...

Full description

Bibliographic Details
Main Authors: Daniela Corona, Burcin Ekser, Rossella Gioco, Massimo Caruso, Chiara Schipa, Pierfrancesco Veroux, Alessia Giaquinta, Antonio Granata, Massimiliano Veroux
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/6/840
_version_ 1827715906186248192
author Daniela Corona
Burcin Ekser
Rossella Gioco
Massimo Caruso
Chiara Schipa
Pierfrancesco Veroux
Alessia Giaquinta
Antonio Granata
Massimiliano Veroux
author_facet Daniela Corona
Burcin Ekser
Rossella Gioco
Massimo Caruso
Chiara Schipa
Pierfrancesco Veroux
Alessia Giaquinta
Antonio Granata
Massimiliano Veroux
author_sort Daniela Corona
collection DOAJ
description Kidney transplantation is a well-established therapy for patients with end-stage renal disease. While a significant improvement of short-term results has been achieved in the short-term, similar results were not reported in the long-term. Heme-oxygenase (HO) is the rate-limiting enzyme in heme catabolism, converting heme to iron, carbon monoxide, and biliverdin. Heme-oxygenase overexpression may be observed in all phases of transplant processes, including brain death, recipient management, and acute and chronic rejection. HO induction has been proved to provide a significant reduction of inflammatory response and a reduction of ischemia and reperfusion injury in organ transplantation, as well as providing a reduction of incidence of acute rejection. In this review, we will summarize data on HO and kidney transplantation, suggesting possible clinical applications in the near future to improve the long-term outcomes.
first_indexed 2024-03-10T19:28:26Z
format Article
id doaj.art-2836859625284863b78271b73fcf16ce
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T19:28:26Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-2836859625284863b78271b73fcf16ce2023-11-20T02:17:55ZengMDPI AGBiomolecules2218-273X2020-05-0110684010.3390/biom10060840Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?Daniela Corona0Burcin Ekser1Rossella Gioco2Massimo Caruso3Chiara Schipa4Pierfrancesco Veroux5Alessia Giaquinta6Antonio Granata7Massimiliano Veroux8Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, ItalyDepartment of Surgery, Indiana University School of Medicine, Indianapolis, IN 46077, USAGeneral Surgery Unit, University Hospital of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, ItalyGeneral Surgery Unit, University Hospital of Catania, 95123 Catania, ItalyOrgan Transplant Unit, University Hospital of Catania, 95123 Catania, ItalyOrgan Transplant Unit, University Hospital of Catania, 95123 Catania, ItalyNephrology Unit, Cannizzaro Hospital, 95026 Catania, ItalyOrgan Transplant Unit, University Hospital of Catania, 95123 Catania, ItalyKidney transplantation is a well-established therapy for patients with end-stage renal disease. While a significant improvement of short-term results has been achieved in the short-term, similar results were not reported in the long-term. Heme-oxygenase (HO) is the rate-limiting enzyme in heme catabolism, converting heme to iron, carbon monoxide, and biliverdin. Heme-oxygenase overexpression may be observed in all phases of transplant processes, including brain death, recipient management, and acute and chronic rejection. HO induction has been proved to provide a significant reduction of inflammatory response and a reduction of ischemia and reperfusion injury in organ transplantation, as well as providing a reduction of incidence of acute rejection. In this review, we will summarize data on HO and kidney transplantation, suggesting possible clinical applications in the near future to improve the long-term outcomes.https://www.mdpi.com/2218-273X/10/6/840kidney transplantationdeceased donorliving donorheme-oxygenaseend-stage renal diseaseorgan transplantation
spellingShingle Daniela Corona
Burcin Ekser
Rossella Gioco
Massimo Caruso
Chiara Schipa
Pierfrancesco Veroux
Alessia Giaquinta
Antonio Granata
Massimiliano Veroux
Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?
Biomolecules
kidney transplantation
deceased donor
living donor
heme-oxygenase
end-stage renal disease
organ transplantation
title Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?
title_full Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?
title_fullStr Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?
title_full_unstemmed Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?
title_short Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?
title_sort heme oxygenase and kidney transplantation a potential for target therapy
topic kidney transplantation
deceased donor
living donor
heme-oxygenase
end-stage renal disease
organ transplantation
url https://www.mdpi.com/2218-273X/10/6/840
work_keys_str_mv AT danielacorona hemeoxygenaseandkidneytransplantationapotentialfortargettherapy
AT burcinekser hemeoxygenaseandkidneytransplantationapotentialfortargettherapy
AT rossellagioco hemeoxygenaseandkidneytransplantationapotentialfortargettherapy
AT massimocaruso hemeoxygenaseandkidneytransplantationapotentialfortargettherapy
AT chiaraschipa hemeoxygenaseandkidneytransplantationapotentialfortargettherapy
AT pierfrancescoveroux hemeoxygenaseandkidneytransplantationapotentialfortargettherapy
AT alessiagiaquinta hemeoxygenaseandkidneytransplantationapotentialfortargettherapy
AT antoniogranata hemeoxygenaseandkidneytransplantationapotentialfortargettherapy
AT massimilianoveroux hemeoxygenaseandkidneytransplantationapotentialfortargettherapy